Moderna vax gets FDA nod for adolescents
Adolescents can be inoculated now that the Food and Drug Administration (FDA) has approve the use of Moderna vaccine for children aged 12 to 17.
The FDA has amended its emergency use application (EUA) issued to Moderna vaccine to include adolescents in the country on Friday, September 3. Moderna applied for the amendment of its EUA two weeks ago.
FDA Director-General Eric Domingo, in a televised briefing, said the approval was the result of “thorough evaluation by our vaccine experts and regulatory experts.”
He clarified, however, that the vaccination of this age group will still follow the priority rules set by the Department of Health (DOH).
The FDA gave the go signal but it is still up to the DOH and the Inter-Agency Task Force (IATF), he said. (John Mahusay)